There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 2 M cells/vial*2 |
| Description | The C1GALT1 knockout HepG2 cell line offers a unique platform for exploring O-glycosylation (Core 1) in liver cancer and its interaction with the hepatic environment. C1GALT1 deficiency impedes Core 1 O-glycan synthesis in HepG2 cells, potentially altering the glycosylation of mucin-like proteins expressed by liver cells. Researchers can analyze the effects of altered O-glycosylation on the tumor microenvironment in the liver, metastasis within the liver, and identify O-glycosylation targets or drugs specific to liver malignancies. |
| Product Type | KO Cell Lines |
| Species | Human |
| Cell Morphology | Epithelial-like, adherent |
| Passage Ratio | 1:4~1:6 |
| Cell Line | HepG2 |
| Primary Disease | Hepatoblastoma |
| Lineage | Liver |
| Lineage Subtype | Hepatoblastoma |
| Cell Viability | >90% |
| Sterility Test | The sterility test indicated an absence of microbial growth. |
| Identity Test | STR identification |
| Mycoplasma Test | Negative |
| Virus Test | Negative for HIV, HBV and HCV. |
| Genetic Stability Testing | We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements. |
| Validation | PCR, Sanger Sequencing |
| Culture Medium | DMEM & FBS & Glutamine |
| Application | Functional assay |
| Size | 2 M cells/vial*2 |
| Product Format | Frozen |
| Shipping | Dry ice |
| Availability Status | Made to order |
| Handling Notes | Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to. |
| Product Disclaimer | This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous. |
| Target | C1GALT1 |
| Full Name | Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-Beta-galactosyltransferase 1 |
| Alternative Name | C1GALT, T-synthase |
| Location | 7p22.1-p21.3 |
| Gene ID | 56913 |
| Summary | Synthesizes core 1 O-glycan (Gal-beta-1-3GalNAc-R) via Gal transfer (UDP-Gal to GalNAc-alpha-1-R); precursor for mucin-type O-glycans (cell surface & secreted) involved in cell signaling and interactions. |